NCT00106418View on ClinicalTrials.gov

A Research Study for Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

May 7, 2003

Primary Completion Date

September 1, 2006

Study Completion Date

September 1, 2006

Conditions

Prostate CancerMetastases

Interventions

DRUG

Romidepsin

13 mg/m2 of romidepsin intravenously over 4 hours on Days 1, 8, and 15 of each 28-day cycle.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY